Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Chimeric Antigen Receptor(Fondazione Policlinico Universitario Agostino Gemelli IRCCS)은 Lymphoma 표적 세포·유전자 치료로, Lymphoma 영역에서 개발·상용화 중입니다. 작용기전: targeting chimeric antigen receptor. 전임상 단계입니다. 대표 임상 효능: ORR 67% (ClinicalTrials.gov NCT03704298). 차별점: novel therapeutics to improve treatment or cure HIV.
Lymphoma
Lymphoma
Recruiting
CAR-T) therapy products for LBCL, yet a systematic comparison of
s
retroviral therapy (ART)-suppressed, HIV-infected humanized DRAGA mice following ART inter
humanized DRAGA mice following ART interruption
novel therapeutics to improve treatment or cure HIV
targeting chimeric antigen receptor
cytokine release syndrome (CRS), all-grade and grade ≥ 3 immune effector cell-associated neurotoxicity syndro
apoptosis of ES cells, upregulated expression of ligands to NK inhibitory receptors on ES cells, and enhanced mouse macrophage mi
biomarker-driven methods were among the clinically orientated themes that emerged from foundational and precl
resistance to NK cells by a combinatorial immunotherapy approach simultaneously enabling NK tumor-specific-targeting via chimeric ant
차트 로드 중…
임상시험이 많습니다. 임상시험 탭에서 Phase/Status 필터·검색을 사용하세요.
수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Chimeric Antigen Receptor(Fondazione Policlinico Universitario Agostino Gemelli IRCCS)은 Lymphoma 표적 세포·유전자 치료로, Lymphoma 영역에서 개발·상용화 중입니다. 작용기전: targeting chimeric antigen receptor. 전임상 단계입니다. 대표 임상 효능: ORR 67% (ClinicalTrials.gov NCT03704298). 차별점: novel therapeutics to improve treatment or cure HIV.
Lymphoma
Lymphoma
Recruiting
CAR-T) therapy products for LBCL, yet a systematic comparison of
s
retroviral therapy (ART)-suppressed, HIV-infected humanized DRAGA mice following ART inter
humanized DRAGA mice following ART interruption
novel therapeutics to improve treatment or cure HIV
targeting chimeric antigen receptor
cytokine release syndrome (CRS), all-grade and grade ≥ 3 immune effector cell-associated neurotoxicity syndro
apoptosis of ES cells, upregulated expression of ligands to NK inhibitory receptors on ES cells, and enhanced mouse macrophage mi
biomarker-driven methods were among the clinically orientated themes that emerged from foundational and precl
resistance to NK cells by a combinatorial immunotherapy approach simultaneously enabling NK tumor-specific-targeting via chimeric ant
차트 로드 중…
임상시험이 많습니다. 임상시험 탭에서 Phase/Status 필터·검색을 사용하세요.
수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다.